Beijing Biostar Pharmaceuticals Co Ltd 2025 Annual Report with Sustainability Disclosures
Company: Beijing Biostar Pharmaceuticals Co Ltd
Sector: Manufacturing
Country: China
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 228
The report covers Biostar's first full operating year after its Main Board listing and reports 2025 Group revenue of RMB33.4 million. Its ESG disclosures quantify 1,529.61 tonnes of total GHG emissions, 2,639,744.94 kWh of energy consumption and 21,729.99 m3 of water consumption. The Group reported 134 employees, including 77 female employees, and no work-related fatalities during the past three years. Governance disclosures place ultimate ESG and climate-risk responsibility with the Board, supported by an ESG working group.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.